HAE Stock Summary and Trading Ideas (Haemonetics | NYSE:HAE)

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

What symbol and exchange does Haemonetics shares trade?

Haemonetics trades on the NYSE stock market under the symbol HAE.

What is Haemonetics stock price doing today?

As of February 19, 2026, HAE stock price climbed to $60.67 with 729,248 million shares trading.

What is Haemonetics's Beta?

HAE has a beta of 0.14, meaning it tends to be less sensitive to market movements. HAE has a correlation of 0.00 to the broad based SPY ETF.

How much is Haemonetics worth?

HAE has a market cap of $2.84 billion. This is considered a Mid Cap stock.

How much money does Haemonetics make?

Last quarter Haemonetics reported $339 million in Revenue and $1.31 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Haemonetics traded in the last 3 year period?

In the last 3 years, HAE traded as high as $97.97 and as low as $47.32.

What are the top ETFs holding Haemonetics?

The top ETF exchange traded funds that HAE belongs to (by Net Assets): VTI, IJH, IWM, VB, VBK.

Is Haemonetics (HAE) a good investment?

HAE has underperformed the market in the last year with a price return of -5.3% while the SPY ETF gained +13.1%. HAE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.5% and -8.0%, respectively, while the SPY returned +4.0% and -0.2%, respectively.

What are the support and resistance levels for Haemonetics (HAE)?

HAE support price is $59.34 and resistance is $61.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HAE shares will trade within this expected range on the day.